JP2022540353A5 - - Google Patents
Info
- Publication number
- JP2022540353A5 JP2022540353A5 JP2021577587A JP2021577587A JP2022540353A5 JP 2022540353 A5 JP2022540353 A5 JP 2022540353A5 JP 2021577587 A JP2021577587 A JP 2021577587A JP 2021577587 A JP2021577587 A JP 2021577587A JP 2022540353 A5 JP2022540353 A5 JP 2022540353A5
- Authority
- JP
- Japan
- Prior art keywords
- compound according
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910572091.9A CN112142743A (zh) | 2019-06-28 | 2019-06-28 | 杂环类化合物、其制备方法及其在医药学上的应用 |
| CN201910572091.9 | 2019-06-28 | ||
| PCT/CN2020/098105 WO2020259584A1 (en) | 2019-06-28 | 2020-06-24 | Heterocyclic compounds for mediating tyrosine kinase 2 activity |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022540353A JP2022540353A (ja) | 2022-09-15 |
| JP2022540353A5 true JP2022540353A5 (enExample) | 2023-06-02 |
| JP7560136B2 JP7560136B2 (ja) | 2024-10-02 |
Family
ID=73869063
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021577587A Active JP7560136B2 (ja) | 2019-06-28 | 2020-06-24 | チロシンキナーゼ２活性を仲介する複素環式化合物 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US12448382B2 (enExample) |
| EP (1) | EP3990449A4 (enExample) |
| JP (1) | JP7560136B2 (enExample) |
| KR (1) | KR102926602B1 (enExample) |
| CN (2) | CN112142743A (enExample) |
| AU (1) | AU2020301437B2 (enExample) |
| BR (1) | BR112021026531A2 (enExample) |
| CA (1) | CA3144799A1 (enExample) |
| MX (1) | MX2021015969A (enExample) |
| PH (1) | PH12021553257A1 (enExample) |
| TW (1) | TWI851747B (enExample) |
| WO (1) | WO2020259584A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112142743A (zh) | 2019-06-28 | 2020-12-29 | 广州诺诚健华医药科技有限公司 | 杂环类化合物、其制备方法及其在医药学上的应用 |
| TWI782599B (zh) * | 2020-07-02 | 2022-11-01 | 美商輝瑞股份有限公司 | 胺基嘧啶基衍生物 |
| CN113234081A (zh) * | 2021-05-27 | 2021-08-10 | 东南大学 | 一种吡咯并吡唑衍生物与dmpeda做脲的制备方法 |
| KR20240111312A (ko) | 2021-10-25 | 2024-07-16 | 카이메라 쎄라퓨틱스 인코포레이티드 | Tyk2 분해제 및 이의 용도 |
| CN122421968A (zh) * | 2023-12-15 | 2026-07-17 | 北京诺诚健华医药科技有限公司 | 特应性皮炎的治疗方法 |
| WO2026086809A1 (en) * | 2024-10-25 | 2026-04-30 | Beijing Innocare Pharma Tech Co., Ltd. | Process for preparing 3- [ (3as, 6ar) -5- {5-chloro-2- [ (1-methyl-1h-pyrazol-4-yl) amino] pyrimidin-4-yl} -3a-methyl-octahydropyrrolo [3, 4-c] pyrrole-2-yl] -3-oxopropionitrile |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2011328237A1 (en) * | 2010-11-09 | 2013-05-23 | Cellzome Limited | Pyridine compounds and aza analogues thereof as TYK2 inhibitors |
| WO2012145581A1 (en) * | 2011-04-20 | 2012-10-26 | Janssen Pharmaceutica Nv | Disubstituted octahy-dropyrrolo [3,4-c] pyrroles as orexin receptor modulators |
| EP2832734A4 (en) * | 2012-03-28 | 2015-08-26 | Takeda Pharmaceutical | HETEROCYCLIC COMPOUND |
| CN105622638B (zh) | 2014-10-29 | 2018-10-02 | 广州必贝特医药技术有限公司 | 嘧啶或吡啶并吡啶酮类化合物及其制备方法和应用 |
| JP6853234B2 (ja) * | 2015-07-09 | 2021-03-31 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングＭｅｒｃｋ Ｐａｔｅｎｔ Ｇｅｓｅｌｌｓｃｈａｆｔ ｍｉｔ ｂｅｓｃｈｒａｅｎｋｔｅｒ Ｈａｆｔｕｎｇ | Ｂｔｋ阻害剤としてのピリミジン誘導体及びその使用 |
| TW201920170A (zh) * | 2017-09-20 | 2019-06-01 | 美商庫拉腫瘤技術股份有限公司 | 經取代之menin-mll 抑制劑及使用方法 |
| CN112142743A (zh) * | 2019-06-28 | 2020-12-29 | 广州诺诚健华医药科技有限公司 | 杂环类化合物、其制备方法及其在医药学上的应用 |
-
2019
- 2019-06-28 CN CN201910572091.9A patent/CN112142743A/zh active Pending
-
2020
- 2020-06-24 PH PH1/2021/553257A patent/PH12021553257A1/en unknown
- 2020-06-24 AU AU2020301437A patent/AU2020301437B2/en active Active
- 2020-06-24 EP EP20832538.1A patent/EP3990449A4/en active Pending
- 2020-06-24 JP JP2021577587A patent/JP7560136B2/ja active Active
- 2020-06-24 CA CA3144799A patent/CA3144799A1/en active Pending
- 2020-06-24 MX MX2021015969A patent/MX2021015969A/es unknown
- 2020-06-24 WO PCT/CN2020/098105 patent/WO2020259584A1/en not_active Ceased
- 2020-06-24 BR BR112021026531A patent/BR112021026531A2/pt unknown
- 2020-06-24 KR KR1020227000934A patent/KR102926602B1/ko active Active
- 2020-06-24 TW TW109121616A patent/TWI851747B/zh active
- 2020-06-24 CN CN202080047732.XA patent/CN114096532B/zh active Active
-
2021
- 2021-12-22 US US17/559,330 patent/US12448382B2/en active Active
-
2025
- 2025-09-29 US US19/343,586 patent/US20260116887A1/en active Pending